Quantcast

Latest Ventricular assist device Stories

2014-02-21 16:23:00

NEW YORK, Feb. 21, 2014 /PRNewswire/ -- Pomerantz LLP has filed a class action lawsuit against Thoratec Corporation ("Thoratec" or the "Company")(NASDAQ: THOR) and certain of its officers. The class action, filed in United States District Court, Northern District of California, and docketed under 14-cv-00360, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Thoratec securities between April 29, 2010 and November 27, 2013 both dates...

2014-02-05 12:27:58

Sanger Heart & Vascular Institute achieves another regional first CHARLOTTE, N.C., Feb. 5, 2014 /PRNewswire-USNewswire/ -- Carolinas HealthCare System today announced it became the first healthcare system in North or South Carolina to implant the total artificial heart (TAH). The surgery was performed at Carolinas Medical Center on January 13, and was led by Eric Skipper, MD, the medical director of adult cardiac surgery at the System's Sanger Heart & Vascular Institute....

2014-02-04 16:29:40

FRAMINGHAM, Mass., Feb. 4, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ:HTWR) has scheduled a conference call to discuss its financial results for the three months ended December 31, 2013, at 8:00 a.m. U.S. Eastern Standard Time on Thursday, February 27, 2014. The Company plans to release the financial results prior to the conference call. The conference call with management will discuss the Company's financial results, highlights from the fourth quarter and business...

2014-02-04 16:28:56

- Revenue of $128.2 million for the fourth quarter of 2013 PLEASANTON, Calif., Feb. 4, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support (MCS) therapies to save, support and restore failing hearts, today reported its financial results for the fourth quarter of 2013. "We were pleased with our financial performance for the fourth quarter and full year, supported by robust growth in the worldwide market for...

2014-02-04 16:28:02

FRAMINGHAM, Mass., Feb. 4, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the 2014 Leerink Global Healthcare Conference at 8:55 a.m. EST on Thursday, February 13, 2014. The conference is being held February 12-13 at the Waldorf Astoria in New York...

2014-01-31 12:25:45

PLEASANTON, Calif., Jan. 31, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Leerink Global Healthcare Conference on Wednesday, February 12. Taylor C. Harris, Vice President and Chief Financial Officer, will provide an update on the company, beginning at 3:05 p.m., Eastern Standard Time (12:05 p.m., Pacific Standard...

2014-01-28 08:29:15

Jack Jones Got His 2nd Chance at Life Because of the World's First and Only FDA, Health Canada and CE (Europe) Approved Total Artificial Heart TUCSON, Ariz., Jan. 28, 2014 /PRNewswire/ -- Even though Greenbrier, Tenn., residents Jack and Mary Jones were 685 miles from home and on vacation, they soon learned that they were in the right place at the right time. (Photo: http://photos.prnewswire.com/prnh/20140128/LA53699) The husband, a farmer, and the wife, an accountant, were in Williamsburg,...

2014-01-23 08:31:02

PLEASANTON, Calif., Jan. 23, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the fourth quarter of fiscal year 2013 on Tuesday, February 4. The company will hold a conference call to discuss its financial results and operating activities, open to all interested parties, at 1:30 p.m., Pacific...

2014-01-14 16:26:14

Fourth Quarter 2013 Revenues Approximately $53 Million; up 62% from Q4 in 2012; 2013 Preliminary Revenues Approximately $208 Million; 87% increase from 2012 FRAMINGHAM, Mass., Jan. 14, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that it expects revenues for the fourth quarter of 2013 will be...


Latest Ventricular assist device Reference Libraries

0_886104d1c1c698f3a531e056704457d5
2010-10-14 16:46:25

The artificial heart, a mechanical heart replacement, is typically used in order to bridge the time to heart transplant or to replace the heart in case a transplant is impossible. Often ventricular assist devices are confused with mechanical hearts because the assist the heart through pumps. They are also different from a cardiopulmonary bypass machine which is an external device used to provide the function of the heart and lungs. CPBs are usually only used for a few hours at a time,...

More Articles (1 articles) »
Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related